Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Magnesium hydroxide 187.5mg tablets
090501300AABKBK
|
Generic compound preparation BNF 0905013 | Other magnesium preparations | Nutrition and Blood | No data available |
|
Magnesium hydroxide 300mg chewable tablets
0101010Q0AAABAB
|
Magnesium hydroxide (Antacid) | Magnesium hydroxide | Gastro-Intestinal System | No data available |
|
Magnesium orotate 500mg tablets
0905013M0AAACAC
|
Magnesium orotate | Magnesium orotate | Nutrition and Blood | No data available |
|
Magnesium oxide 10mg capsules
0101010I0AAAJAJ
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 133mg tablets
0101010I0AABPBP
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 150mg/5ml oral suspension
0101010I0AAAVAV
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 160mg/5ml oral suspension
0101010I0AABGBG
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 187.5mg tablets
0101010I0AABUBU
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 200mg capsules
0101010I0AAADAD
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 250mg capsules
0101010I0AAAMAM
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 250mg tablets
0101010I0AABSBS
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 280mg capsules
0101010I0AABTBT
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 300mg capsules
0101010I0AAAUAU
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 320mg capsules
0101010I0AAATAT
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 375mg capsules
0101010I0AABQBQ
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 400mg capsules
0101010I0AAAHAH
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 500mg tablets
0101010I0AAAXAX
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide heavy 100mg capsules
190400000AAUJUJ
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Magnesium sulf 50% (magnesium 2mmol/ml) inj 4ml Minijet pfs
0905013N0BBAAAW
|
Minjet magnesium sulfate | Magnesium sulfate | Nutrition and Blood | No data available |
|
Magnesium sulfate 20% (magnesium 0.8mmol/ml) inj 20ml amp
0905013N0AAASAS
|
Magnesium sulfate (Supplements) | Magnesium sulfate | Nutrition and Blood | No data available |
|
Magnesium sulfate 50% (magnesium 2mmol/ml) inf 100ml vials
0905013N0AABBBB
|
Magnesium sulfate (Supplements) | Magnesium sulfate | Nutrition and Blood | No data available |
|
Magnesium sulfate 50% (magnesium 2mmol/ml) inf 50ml vials
0905013N0AABABA
|
Magnesium sulfate (Supplements) | Magnesium sulfate | Nutrition and Blood | No data available |
|
Magnesium sulfate 50% (magnesium 2mmol/ml) inj 10ml pfs
0905013N0AAARAR
|
Magnesium sulfate (Supplements) | Magnesium sulfate | Nutrition and Blood | No data available |
|
Magnesium sulfate 50% (magnesium 2mmol/ml) inj 20ml vials
0905013N0AAAZAZ
|
Magnesium sulfate (Supplements) | Magnesium sulfate | Nutrition and Blood | No data available |
|
Magnesium sulfate 50% (magnesium 2mmol/ml) inj 4ml pfs
0905013N0AAAWAW
|
Magnesium sulfate (Supplements) | Magnesium sulfate | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.